Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

M.D., Beyoglu Eye Training and Research Hospital, Istanbul/TURKEY In this case report, we presented the clinical and therapeutic outcomes of a wet AMD patient who was a well-responder to ranibizumab treatment for three years and who showed a serious clinical picture at the beginning of the third year and had become anti-VEGF non-responder. Keywords : Ranibizumab, age related macular degeneration